カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の眼科用薬物送達システム市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Ophthalmic Drug Delivery System Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22MY8231）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22MY8231
■ 発行日：2022年5月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：123
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の眼科用薬物送達システム市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

眼科用薬物送達システム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の眼科用薬物送達システムの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

眼科用薬物送達システム市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・埋め込み型眼科用薬物送達システム、粒子型眼科用薬物送達システム、その他

用途別セグメントは次のように区分されます。
・病院、クリニック、外来手術センター、その他

世界の眼科用薬物送達システム市場の主要な市場プレーヤーは以下のとおりです。
・Aero Pump GmbH、AptarGroup、Bausch Health、Becton Dickinson & Company、EyePoint Pharmaceuticals, Inc.、Gaplast GmbH、Gerresheimer、Nemera、Nipro Corporation、Ocular Therapeutix、Owen Mumford、Silgan Holdings Inc.、Terumo Corporation、West Pharmaceutical Services, Inc.、Kedalion Therapeutics、Re-Vana Therapeutics、Mati Therapeutics, Inc.,、Biocorp Production、Ocumedic, Inc.、Graybug Vision、Taiwan Liposome、Santen Pharmaceutical、Envisia Therapeutics、Clearside Biomedical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、眼科用薬物送達システム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な眼科用薬物送達システムメーカーの企業概要、2019年～2022年までの眼科用薬物送達システムの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な眼科用薬物送達システムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別眼科用薬物送達システムの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの眼科用薬物送達システムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での眼科用薬物送達システム市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および眼科用薬物送達システムの産業チェーンを掲載しています。
・第13、14、15章では、眼科用薬物送達システムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Aero Pump GmbH、AptarGroup、Bausch Health、Becton Dickinson & Company、EyePoint Pharmaceuticals, Inc.、Gaplast GmbH、Gerresheimer、Nemera、Nipro Corporation、Ocular Therapeutix、Owen Mumford、Silgan Holdings Inc.、Terumo Corporation、West Pharmaceutical Services, Inc.、Kedalion Therapeutics、Re-Vana Therapeutics、Mati Therapeutics, Inc.,、Biocorp Production、Ocumedic, Inc.、Graybug Vision、Taiwan Liposome、Santen Pharmaceutical、Envisia Therapeutics、Clearside Biomedical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：埋め込み型眼科用薬物送達システム、粒子型眼科用薬物送達システム、その他
・用途別分析2017年-2028年：病院、クリニック、外来手術センター、その他
・眼科用薬物送達システムの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・眼科用薬物送達システムのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・眼科用薬物送達システムのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・眼科用薬物送達システムの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・眼科用薬物送達システムの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Ophthalmic Drug Delivery System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Ophthalmic Drug Delivery System market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Ophthalmic Drug Delivery System global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Implantable Ophthalmic Drug Delivery Systems segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Ophthalmic Drug Delivery System include Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, and EyePoint Pharmaceuticals, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Ophthalmic Drug Delivery System market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Implantable Ophthalmic Drug Delivery Systems
Particulate Ophthalmic Drug Delivery Systems
Others
Market segment by Application can be divided into
Hospitals
Clinics
Ambulatory Surgical Centers
Others
The key market players for global Ophthalmic Drug Delivery System market are listed below:
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson & Company
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.
Graybug Vision
Taiwan Liposome
Santen Pharmaceutical
Envisia Therapeutics
Clearside Biomedical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ophthalmic Drug Delivery System product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ophthalmic Drug Delivery System, with price, sales, revenue and global market share of Ophthalmic Drug Delivery System from 2019 to 2022.
Chapter 3, the Ophthalmic Drug Delivery System competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ophthalmic Drug Delivery System breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Ophthalmic Drug Delivery System market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Ophthalmic Drug Delivery System.
Chapter 13, 14, and 15, to describe Ophthalmic Drug Delivery System sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Ophthalmic Drug Delivery System Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ophthalmic Drug Delivery System Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Implantable Ophthalmic Drug Delivery Systems
1.2.3 Particulate Ophthalmic Drug Delivery Systems
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Ophthalmic Drug Delivery System Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Ophthalmic Drug Delivery System Market Size & Forecast
1.4.1 Global Ophthalmic Drug Delivery System Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Ophthalmic Drug Delivery System Sales in Volume (2017-2028)
1.4.3 Global Ophthalmic Drug Delivery System Price (2017-2028)
1.5 Global Ophthalmic Drug Delivery System Production Capacity Analysis
1.5.1 Global Ophthalmic Drug Delivery System Total Production Capacity (2017-2028)
1.5.2 Global Ophthalmic Drug Delivery System Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ophthalmic Drug Delivery System Market Drivers
1.6.2 Ophthalmic Drug Delivery System Market Restraints
1.6.3 Ophthalmic Drug Delivery System Trends Analysis
2 Manufacturers Profiles
2.1 Aero Pump GmbH
2.1.1 Aero Pump GmbH Details
2.1.2 Aero Pump GmbH Major Business
2.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Product and Services
2.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AptarGroup
2.2.1 AptarGroup Details
2.2.2 AptarGroup Major Business
2.2.3 AptarGroup Ophthalmic Drug Delivery System Product and Services
2.2.4 AptarGroup Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bausch Health
2.3.1 Bausch Health Details
2.3.2 Bausch Health Major Business
2.3.3 Bausch Health Ophthalmic Drug Delivery System Product and Services
2.3.4 Bausch Health Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Becton Dickinson & Company
2.4.1 Becton Dickinson & Company Details
2.4.2 Becton Dickinson & Company Major Business
2.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Product and Services
2.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 EyePoint Pharmaceuticals, Inc.
2.5.1 EyePoint Pharmaceuticals, Inc. Details
2.5.2 EyePoint Pharmaceuticals, Inc. Major Business
2.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product and Services
2.5.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Gaplast GmbH
2.6.1 Gaplast GmbH Details
2.6.2 Gaplast GmbH Major Business
2.6.3 Gaplast GmbH Ophthalmic Drug Delivery System Product and Services
2.6.4 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Gerresheimer
2.7.1 Gerresheimer Details
2.7.2 Gerresheimer Major Business
2.7.3 Gerresheimer Ophthalmic Drug Delivery System Product and Services
2.7.4 Gerresheimer Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Nemera
2.8.1 Nemera Details
2.8.2 Nemera Major Business
2.8.3 Nemera Ophthalmic Drug Delivery System Product and Services
2.8.4 Nemera Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Nipro Corporation
2.9.1 Nipro Corporation Details
2.9.2 Nipro Corporation Major Business
2.9.3 Nipro Corporation Ophthalmic Drug Delivery System Product and Services
2.9.4 Nipro Corporation Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Ocular Therapeutix
2.10.1 Ocular Therapeutix Details
2.10.2 Ocular Therapeutix Major Business
2.10.3 Ocular Therapeutix Ophthalmic Drug Delivery System Product and Services
2.10.4 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Owen Mumford
2.11.1 Owen Mumford Details
2.11.2 Owen Mumford Major Business
2.11.3 Owen Mumford Ophthalmic Drug Delivery System Product and Services
2.11.4 Owen Mumford Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Silgan Holdings Inc.
2.12.1 Silgan Holdings Inc. Details
2.12.2 Silgan Holdings Inc. Major Business
2.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Product and Services
2.12.4 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Terumo Corporation
2.13.1 Terumo Corporation Details
2.13.2 Terumo Corporation Major Business
2.13.3 Terumo Corporation Ophthalmic Drug Delivery System Product and Services
2.13.4 Terumo Corporation Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 West Pharmaceutical Services, Inc.
2.14.1 West Pharmaceutical Services, Inc. Details
2.14.2 West Pharmaceutical Services, Inc. Major Business
2.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product and Services
2.14.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Kedalion Therapeutics
2.15.1 Kedalion Therapeutics Details
2.15.2 Kedalion Therapeutics Major Business
2.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Product and Services
2.15.4 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Re-Vana Therapeutics
2.16.1 Re-Vana Therapeutics Details
2.16.2 Re-Vana Therapeutics Major Business
2.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Product and Services
2.16.4 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Mati Therapeutics, Inc.,
2.17.1 Mati Therapeutics, Inc., Details
2.17.2 Mati Therapeutics, Inc., Major Business
2.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product and Services
2.17.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Biocorp Production
2.18.1 Biocorp Production Details
2.18.2 Biocorp Production Major Business
2.18.3 Biocorp Production Ophthalmic Drug Delivery System Product and Services
2.18.4 Biocorp Production Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Ocumedic, Inc.
2.19.1 Ocumedic, Inc. Details
2.19.2 Ocumedic, Inc. Major Business
2.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Product and Services
2.19.4 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Graybug Vision
2.20.1 Graybug Vision Details
2.20.2 Graybug Vision Major Business
2.20.3 Graybug Vision Ophthalmic Drug Delivery System Product and Services
2.20.4 Graybug Vision Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Taiwan Liposome
2.21.1 Taiwan Liposome Details
2.21.2 Taiwan Liposome Major Business
2.21.3 Taiwan Liposome Ophthalmic Drug Delivery System Product and Services
2.21.4 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Santen Pharmaceutical
2.22.1 Santen Pharmaceutical Details
2.22.2 Santen Pharmaceutical Major Business
2.22.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Product and Services
2.22.4 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Envisia Therapeutics
2.23.1 Envisia Therapeutics Details
2.23.2 Envisia Therapeutics Major Business
2.23.3 Envisia Therapeutics Ophthalmic Drug Delivery System Product and Services
2.23.4 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Clearside Biomedical
2.24.1 Clearside Biomedical Details
2.24.2 Clearside Biomedical Major Business
2.24.3 Clearside Biomedical Ophthalmic Drug Delivery System Product and Services
2.24.4 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Ophthalmic Drug Delivery System Breakdown Data by Manufacturer
3.1 Global Ophthalmic Drug Delivery System Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Ophthalmic Drug Delivery System Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Ophthalmic Drug Delivery System
3.4 Market Concentration Rate
3.4.1 Top 3 Ophthalmic Drug Delivery System Manufacturer Market Share in 2021
3.4.2 Top 6 Ophthalmic Drug Delivery System Manufacturer Market Share in 2021
3.5 Global Ophthalmic Drug Delivery System Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Ophthalmic Drug Delivery System Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ophthalmic Drug Delivery System Market Size by Region
4.1.1 Global Ophthalmic Drug Delivery System Sales in Volume by Region (2017-2028)
4.1.2 Global Ophthalmic Drug Delivery System Revenue by Region (2017-2028)
4.2 North America Ophthalmic Drug Delivery System Revenue (2017-2028)
4.3 Europe Ophthalmic Drug Delivery System Revenue (2017-2028)
4.4 Asia-Pacific Ophthalmic Drug Delivery System Revenue (2017-2028)
4.5 South America Ophthalmic Drug Delivery System Revenue (2017-2028)
4.6 Middle East and Africa Ophthalmic Drug Delivery System Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Ophthalmic Drug Delivery System Sales in Volume by Type (2017-2028)
5.2 Global Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
5.3 Global Ophthalmic Drug Delivery System Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Ophthalmic Drug Delivery System Sales in Volume by Application (2017-2028)
6.2 Global Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
6.3 Global Ophthalmic Drug Delivery System Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Ophthalmic Drug Delivery System Sales by Type (2017-2028)
7.2 North America Ophthalmic Drug Delivery System Sales by Application (2017-2028)
7.3 North America Ophthalmic Drug Delivery System Market Size by Country
7.3.1 North America Ophthalmic Drug Delivery System Sales in Volume by Country (2017-2028)
7.3.2 North America Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Ophthalmic Drug Delivery System Sales by Type (2017-2028)
8.2 Europe Ophthalmic Drug Delivery System Sales by Application (2017-2028)
8.3 Europe Ophthalmic Drug Delivery System Market Size by Country
8.3.1 Europe Ophthalmic Drug Delivery System Sales in Volume by Country (2017-2028)
8.3.2 Europe Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Ophthalmic Drug Delivery System Sales by Type (2017-2028)
9.2 Asia-Pacific Ophthalmic Drug Delivery System Sales by Application (2017-2028)
9.3 Asia-Pacific Ophthalmic Drug Delivery System Market Size by Region
9.3.1 Asia-Pacific Ophthalmic Drug Delivery System Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Ophthalmic Drug Delivery System Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Ophthalmic Drug Delivery System Sales by Type (2017-2028)
10.2 South America Ophthalmic Drug Delivery System Sales by Application (2017-2028)
10.3 South America Ophthalmic Drug Delivery System Market Size by Country
10.3.1 South America Ophthalmic Drug Delivery System Sales in Volume by Country (2017-2028)
10.3.2 South America Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ophthalmic Drug Delivery System Sales by Type (2017-2028)
11.2 Middle East & Africa Ophthalmic Drug Delivery System Sales by Application (2017-2028)
11.3 Middle East & Africa Ophthalmic Drug Delivery System Market Size by Country
11.3.1 Middle East & Africa Ophthalmic Drug Delivery System Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Ophthalmic Drug Delivery System and Key Manufacturers
12.2 Manufacturing Costs Percentage of Ophthalmic Drug Delivery System
12.3 Ophthalmic Drug Delivery System Production Process
12.4 Ophthalmic Drug Delivery System Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Ophthalmic Drug Delivery System Typical Distributors
13.3 Ophthalmic Drug Delivery System Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の注射可能ドラッグデリバリー機器市場2022年：市場規模予測（～2028年）
  • 世界の非侵襲式薬物送達市場2022年：市場規模予測（～2028年）
  • 世界の注射可能ドラッグデリバリーデバイス市場2022年：市場規模予測（～2028年）
  • 世界の輸液ドラッグデリバリーデバイス市場2022年：市場規模予測（～2028年）
  • 世界の眼科用B-スキャン超音波装置市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22MY8231 )"世界の眼科用薬物送達システム市場2022年：市場規模予測（～2028年）" (英文：Global Ophthalmic Drug Delivery System Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。